Indian Immunologicals Limited

AI Revolutionizes HBV Vaccine Development as Global Market Grows at a CAGR of 5.33% - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 9, 2023
Technology, Infectious Diseases, Health, Artificial Intelligence, WHO, Bioinformatics, LG Chem, Drug design, Intelligence, Composition, Incidence, Pregnancy, Vaccine, Government, ROW, Prevalence, Indian Immunologicals Limited, GSK plc, Merck, Data science, Mother, Vaccination, Liver cancer, Genomics, Transport, COVAX, COVID-19, Antibody, KM, Microbiology, Machine learning, Biochemistry, Blood, Hepatitis A and B vaccine, Serum, Hepatitis B virus, Public, Sanofi, Hepatitis, Hepatitis B, Immunization, Pediatrics, World Health Organization's response to the COVID-19 pandemic, Compound annual growth rate, HBV, Parent, Cirrhosis, Merck & Co.

The HBV vaccine stands as a crucial tool in the World Health Organization's (WHO) mission to eliminate HBV by 2030.

Key Points: 
  • The HBV vaccine stands as a crucial tool in the World Health Organization's (WHO) mission to eliminate HBV by 2030.
  • Since the approval of the first HBV vaccine in 1981, significant advancements have occurred in the development of HBV vaccines.
  • The United States leads the global market due to a high demand for the HBV vaccine, driven by ongoing HBV infection threats.
  • The integration of AI in vaccine and drug design is poised to accelerate vaccine development, enhance efficacy, and drive the HBV vaccine market's growth.

Global Foot and Mouth Disease Vaccine Market to Surpass US$ 4,919.7 Million by 2030 - Coherent Market Insights

Retrieved on: 
Wednesday, July 27, 2022
MSD, Milk, Livestock, Indian Immunologicals Limited, Awareness, Center, Bayer, FMD, Foot, Government, Incidence, Traction, US, Agriculture, PubMed, CAGR, Meat, Ministry, Dairy, Grupo Lala, Ruminant, Vaccination, Schering-Plough, Analysis, Animal, Ministry of Agriculture (Azerbaijan), Miniature pig, Vaccine, Pharmaceutical industry, Merck & Co.

Key Trends and Analysis of the Global Foot and Mouth Disease Vaccine Market:

Key Points: 
  • Key Trends and Analysis of the Global Foot and Mouth Disease Vaccine Market:
    Increasing number of livestock in different regions is increasing vulnerability for Foot and Mouth Disease outbreak.
  • Global foot and mouth disease vaccine market is expected to exhibit a CAGR of 9.4% during the forecast period due to increasing government initiatives for creating awareness about carrying out vaccination for foot and mouth disease for animals.
  • With the administration of FMD vaccine, Indonesia is expected to become free from the foot and mouth disease up till 2028.
  • Global Foot and Mouth Disease Vaccine Market, By Vaccine Type:

Global Foot and Mouth Disease Vaccine Market to Surpass US$ 4,919.7 Million by 2030 - Coherent Market Insights

Retrieved on: 
Wednesday, July 27, 2022
MSD, Milk, Livestock, Indian Immunologicals Limited, Awareness, Center, Bayer, FMD, Foot, Government, Incidence, Traction, US, Agriculture, PubMed, CAGR, Meat, Ministry, Dairy, Grupo Lala, Ruminant, Vaccination, Schering-Plough, Analysis, Animal, Ministry of Agriculture (Azerbaijan), Miniature pig, Vaccine, Pharmaceutical industry, Merck & Co.

Key Trends and Analysis of the Global Foot and Mouth Disease Vaccine Market:

Key Points: 
  • Key Trends and Analysis of the Global Foot and Mouth Disease Vaccine Market:
    Increasing number of livestock in different regions is increasing vulnerability for Foot and Mouth Disease outbreak.
  • Global foot and mouth disease vaccine market is expected to exhibit a CAGR of 9.4% during the forecast period due to increasing government initiatives for creating awareness about carrying out vaccination for foot and mouth disease for animals.
  • With the administration of FMD vaccine, Indonesia is expected to become free from the foot and mouth disease up till 2028.
  • Global Foot and Mouth Disease Vaccine Market, By Vaccine Type:

Global Veterinary Vaccines Market Outlook 2022-2028: Growing Use of Vaccines in the American and European Markets - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 2, 2022
Veterinary, Health, Meat Products of India, Indian Immunologicals Limited, Animal, D, Veterinarian, Awareness, Schering-Plough, Vaccine, Growth, Livestock, CAGR

The global veterinary vaccines market is projected to register growth at a CAGR of 7.46% over the forecasted years 2022-2028.

Key Points: 
  • The global veterinary vaccines market is projected to register growth at a CAGR of 7.46% over the forecasted years 2022-2028.
  • The market's growth is augmented due to factors such as the rise in the animal population & diseases and advancements in vaccines.
  • The global veterinary vaccines market encompasses Europe, North America, the Asia-Pacific, and Latin America.
  • On the other hand, North America has presented itself as the leader in the veterinary vaccines market.

VESTECK, Inc. Delivers multiple presentations at Charring Cross International Symposium

Retrieved on: 
Wednesday, May 11, 2022
Dai, University, CX, Shark Tank, Elective surgery, EVAR, Aorta, Physician, Patient, Associate, Johannes Hoffmann (vascular surgeon), University of Wisconsin School of Medicine and Public Health, Internet, View, Solution, Technology, Indian Immunologicals Limited, Multimedia, Medical device

WEST CHESTER, Pa., May 11, 2022 /PRNewswire/ -- VESTECK, Inc. is pleased to announce their participation and strong podium presence at the Charring Cross International Vascular Symposium.

Key Points: 
  • WEST CHESTER, Pa., May 11, 2022 /PRNewswire/ -- VESTECK, Inc. is pleased to announce their participation and strong podium presence at the Charring Cross International Vascular Symposium.
  • "Charring Cross" (CX), held annually in London, UK, is considered one of the premier global Vascular/Endovascular symposiums.
  • Key Opinion Leaders from around the world assemble to candidly discuss the most recent breakthroughs and controversies.
  • CX attendees spent an entire day discussing solutions to the current challenges with the durability of endovascular aortic repair grafts (EVAR/TEVAR).

World Swine Vaccines Market Report 2022: Focus on Products (Recombinant, Inactivated), & Type (Pseudorabies, Porcine Circovirus Type 2) - Forecast to 2028 - ResearchAndMarkets.com

Retrieved on: 
Friday, January 21, 2022
Agriculture, Natural Resources, Health, Veterinary, Pharmaceutical, CAGR, Research, Technology, Vaccine, ICAR, PCV2, ALCO RS-2, Indian Veterinary Research Institute, Urbanization, COVID-19, Virus, Porcine reproductive and respiratory syndrome virus 2, Growth, Atmosphere, Farm, Disease, PRRS, Animal Health, DNA, Health, Infection, Betaarterivirus suid 1, Industry, Classical swine fever, IVRI, PPV, Diagnosis, Miniature pig, USD, Mutation, Bareilly, Prevalence, Foot, Indian Immunologicals Limited, Investment, Awareness, Aquaculture

The "Swine Vaccines Market Size, Share & Trends Analysis Report 2021-2028" has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Swine Vaccines Market Size, Share & Trends Analysis Report 2021-2028" has been added to ResearchAndMarkets.com's offering.
  • Porcine Parvovirus (PPV), Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine circovirus type 2 (PCV2), Foot & Mouth Disease, Classical Swine Fever, and others remain to be extremely prevalent diseases in pig farms affecting economic losses.
  • The COVID-19 pandemic directly or indirectly impacted the business, results of operations, and financial conditions of market players.
  • In addition, the growing investments by key players to develop advanced products for better diagnosis are likely to propel market growth.

Pediatric Vaccine Global Market Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Friday, August 6, 2021
Infectious Diseases, Pharmaceutical, Health, Growth, Knowledge, AstraZeneca, Indian Immunologicals Limited, Prevalence, Pfizer, Vaccination, Polio, Woman, Vaccine, Streptococcus agalactiae, COVID-19, Tetanus, Antibody, Maurice Hilleman, Whooping cough, Neonatal infection, Merck & Co., Policy, Parent, Mitsubishi Tanabe Pharma, HIV/ AIDS, Cancer, Immunization, Immunity, Hepatitis B, Neurodegeneration, Conditional sentence, CSL Limited, Risk, Health, Pneumonia, Infection, GlaxoSmithKline, Diphtheria, Child, Tuberculosis, Animal, Pharmaceutical industry

The "Pediatric Vaccine Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pediatric Vaccine Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.
  • Pediatric Vaccine Global Market Report 2021: COVID-19 Growth and Change to 2030 provides the strategists, marketers and senior management with the critical information they need to assess the global pediatric vaccines market.
  • The pediatric vaccines market consists of sales of pediatric vaccines and its related services used to provide immunity to infants and children for specific diseases.
  • To meet the increasing demand for novel vaccines, there is a continuous quest for pediatric vaccine manufacturers and developers for innovation of vaccine design and manufacturing technologies.

Vaccines Market Worth $58.4 Billion by 2024 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, January 29, 2020
Vaccines, Medical specialties, Vaccination, Vaccine, Virology, Medicine, Microbiology, Conjugate vaccine, RTT, Pentavalent vaccine, Indian Immunologicals Limited

By technology, the conjugate vaccines segment accounted for the largest market share in 2018.

Key Points: 
  • By technology, the conjugate vaccines segment accounted for the largest market share in 2018.
  • On the basis of technology, the Vaccines Market has been segmented into conjugate vaccines, inactivated and subunit vaccines, live attenuated vaccines, recombinant vaccines, and toxoid vaccines.
  • The conjugate vaccines segment accounted for the largest share of the market in 2018.
  • On the basis of type, the Vaccines Market has been segmented into monovalent and multivalent vaccines.

Vaccines Market Worth $58.4 Billion by 2024 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, January 29, 2020
Vaccines, Medical specialties, Vaccination, Vaccine, Virology, Medicine, Microbiology, Conjugate vaccine, RTT, Pentavalent vaccine, Indian Immunologicals Limited

By technology, the conjugate vaccines segment accounted for the largest market share in 2018.

Key Points: 
  • By technology, the conjugate vaccines segment accounted for the largest market share in 2018.
  • On the basis of technology, the Vaccines Market has been segmented into conjugate vaccines, inactivated and subunit vaccines, live attenuated vaccines, recombinant vaccines, and toxoid vaccines.
  • The conjugate vaccines segment accounted for the largest share of the market in 2018.
  • On the basis of type, the Vaccines Market has been segmented into monovalent and multivalent vaccines.

Veterinary Vaccines Market Worth 8.66 Billion USD by 2022, at a CAGR of 5.9% - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, July 2, 2019
Vaccines, Vaccination, Vaccine, Virology, Medicine, Inactivated vaccine, Medical specialties, Clinical medicine, Indian Immunologicals Limited, Hester Biosciences

Based on the type, the Veterinary Vaccines Market is segmented into porcine vaccines, poultry vaccines, livestock vaccines, companion animal vaccines, aquaculture vaccines and other animal vaccines.

Key Points: 
  • Based on the type, the Veterinary Vaccines Market is segmented into porcine vaccines, poultry vaccines, livestock vaccines, companion animal vaccines, aquaculture vaccines and other animal vaccines.
  • In 2017, the porcine vaccines segment is expected to account for the largest share of the Animal Vaccines Market.
  • On the basis of technology, the Animal Vaccines Marketis classified into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, and other vaccines.
  • The recombinant vaccines segment is the fastest-growing technology segment in the Veterinary Vaccines Market.